Both in Pharmaceuticals
Atossa Therapeutics vs Neuphoria Therapeutics
Over the past year ATOS returned −84.8% and NEUP returned −69.9%; their daily moves had a correlation of 0.10.
ATOS −84.8% NEUP −69.9%Growth of $1, one year, split-adjusted
| Metric | ATOS | NEUP |
|---|---|---|
| Price | $1.99 | $3.57 |
| Market cap | $19.9M | $19.3M |
| Today | +1.53% | −2.19% |
| 1 month | −22.9% | −5.1% |
| 6 months | −57.7% | −9.4% |
| Year to date | −77.5% | −8.0% |
| 1 year | −84.5% | −71.0% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $26.1M | — |
| Dividend yield | — | — |
| Volatility (60d) | 63.4% | 44.8% |
| Short % of float | 8.6% | 0.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).